Consistent with its role in apoptosis modulation, 4-MU significantly altered critical regulators of cell death in H22 tumor-bearing mice: Bax expression progressively intensified with escalating drug concentrations (Fig. 8B), whereas Bcl-2 expression exhibited reciprocal attenuation (Fig. 8C). Here, BCL2 is linked to neoplasm.